DOI:

EAPCI, EuroIntervention and EuroPCR... together

William Wijns*, President, EAPCI

A new beginning

For many of you attending the EuroPCR this year the big difference will be the country we are meeting in. For the first time in the history of this scientific gathering we will be leaving France and heading for Spain and Barcelona. But for us, the EuroPCR has another aspect, one which sets it apart from all previous years, because this year it is OUR meeting as well.

We have said this many times before, but it values repeating: the EAPCI, the direct outgrowth of all our collaborative efforts – whether on the WG10, or in our national meetings throughout Europe, or in the EuroPCR itself – has been created as the next step in the evolution of our profession. From now on, and since our official founding last year at the ESC meeting, through our collaboration with this journal and the EuroPCR, we are all intimately connected – a symbiotic relationship that will only help progress our speciality.

A common goal

In a recent interview, Jean Fajadet, whose specific role as the current chair of our international affairs and national societies committee is to “facilitate and optimize the communication between EAPCI and all national interventional cardiology working groups”, underlined our efforts. A key element in our founding philosophy is our dedication to building close collaborative relationships between ourselves and all national groups through formal and direct contact. The goal is simple, we need to incite, inspire and encourage active involvement by these national working groups with the EuroPCR and the annual meeting of EAPCI in order to be the vital organisation that we set out to be.

We must remember that the EAPCI welcomes all professionals whose main activity is percutaneous cardiovascular interventions and who want to participate in our common goals of clinical research, scientific activities, and education in order to improve interventional procedures and the quality of patient care. As an example of this, Jean points to such activities as the successful (and oversubscribed!) Fellows course run last November in London by Carlo di Mario and George Dangas which offered preparation for future European certification exams in interventional cardiology.

More information on all our various activities can be found on our website at: www.escardio.org/bodies/associations/EAPCI

You make the difference

It is clear for those of us already active in the EAPCI that the difference is you, the individual practitioner. We are committed to building our speciality together, and your participation, whether on a local level, in our European-wide registries or meetings are crucial for all of us. It is for these reasons that the program of the EAPCI is of such seminal importance at this year’s EuroPCR, because it underlines the reality of this new dynamic.

We look forward to your joining us there.

Highlights of these meeting include:

Update on EuroHeart Survey and European registries

Tuesday, the 22nd May

16:30-18:30 in room 5

ESC@EuroPCR - the first disclosure of the new ESC guidelines on treatment of non- STEMI

Wednesday, the 23rd May

18:00-19:30 in room 5

EAPCI General Assembly

Thursday, the 24th May

18:00-19:30 in room 5

Awards ceremony – EAPCI Fellowship awards

to be presented by Antoine Lafont.

Friday, the 25th May - 12:00-12:30 in room 1

Volume 3 Number 1
May 22, 2007
Volume 3 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al

Original Research

10.4244/EIJ-D-25-01268 Jun 1, 2026
Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry
Tarantini G et al

Research Correspondence

10.4244/EIJ-D-25-01160 Jun 1, 2026
First-in-human experience with a heterotopic cross-caval transcatheter tricuspid valve replacement
Estevez-Loureiro R et al

Original Research

10.4244/EIJ-D-26-00416 May 21, 2026
Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study
Volleberg R et al
Trending articles
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
34.8

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
20.75

Flashlight

10.4244/EIJ-D-25-01014 Apr 6, 2026
Stent retriever-assisted coronary thrombectomy with continuous aspiration
Liabot Q et al
open access
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
17.8

Expert Review

10.4244/EIJ-D-25-01316 Apr 20, 2026
Electrosurgical laceration and stabilisation of tricuspid edge-to-edge repair: the ELASTA-T technique
Alvarez-Covarrubias H et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved